Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wataru Okamoto

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|September 19, 2013
A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumorsWataru Okamoto, Takayuki Yoshino, Toshiaki Takahashi, et al.
Clinical Colorectal Cancer|October 27, 2016
Prophylactic Use of Oral Dexamethasone to Alleviate Fatigue During Regorafenib Treatment for Patients With Metastatic Colorectal CancerShota Fukuoka, Kohei Shitara, Masaaki Noguchi, et al.
Oncotarget|January 19, 2013
MET amplification as a potential therapeutic target in gastric cancerHisato Kawakami, Isamu Okamoto, Tokuzo Arao, et al.
Clinical Colorectal Cancer|January 3, 2016
Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single InstitutionDaisuke Kotani, Kohei Shitara, Akihito Kawazoe, et al.
Clinical Colorectal Cancer|June 6, 2018
Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal CancerKentaro Sawada, Yoshiaki Nakamura, Takeharu Yamanaka, et al.
Japanese Journal of Clinical Oncology|April 17, 2018
Feasibility study of cancer genome alterations identified by next generation sequencing: ABC studyYoichi Naito, Hideaki Takahashi, Kohei Shitara, et al.
ACS Applied Bio Materials|November 18, 2022
Core-Shell Structured Hemoglobin Nanoparticles as Artificial O<sub>2</sub> CarriersWataru Okamoto, Mai Hasegawa, Natsumi Kohyama, et al.
BMC Cancer|March 23, 2019
Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapyKazuaki Harada, Wataru Okamoto, Sachiyo Mimaki, et al.
Investigational New Drugs|March 17, 2015
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experienceAkihito Kawazoe, Kohei Shitara, Shota Fukuoka, et al.
BMC Cancer|April 18, 2015
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancerAkihito Kawazoe, Kohei Shitara, Shota Fukuoka, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|September 19, 2013
A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumorsWataru Okamoto, Takayuki Yoshino, Toshiaki Takahashi, et al.
Clinical Colorectal Cancer|October 27, 2016
Prophylactic Use of Oral Dexamethasone to Alleviate Fatigue During Regorafenib Treatment for Patients With Metastatic Colorectal CancerShota Fukuoka, Kohei Shitara, Masaaki Noguchi, et al.
Oncotarget|January 19, 2013
MET amplification as a potential therapeutic target in gastric cancerHisato Kawakami, Isamu Okamoto, Tokuzo Arao, et al.
Clinical Colorectal Cancer|January 3, 2016
Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single InstitutionDaisuke Kotani, Kohei Shitara, Akihito Kawazoe, et al.
Clinical Colorectal Cancer|June 6, 2018
Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal CancerKentaro Sawada, Yoshiaki Nakamura, Takeharu Yamanaka, et al.
Japanese Journal of Clinical Oncology|April 17, 2018
Feasibility study of cancer genome alterations identified by next generation sequencing: ABC studyYoichi Naito, Hideaki Takahashi, Kohei Shitara, et al.
ACS Applied Bio Materials|November 18, 2022
Core-Shell Structured Hemoglobin Nanoparticles as Artificial O<sub>2</sub> CarriersWataru Okamoto, Mai Hasegawa, Natsumi Kohyama, et al.
BMC Cancer|March 23, 2019
Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapyKazuaki Harada, Wataru Okamoto, Sachiyo Mimaki, et al.
Investigational New Drugs|March 17, 2015
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experienceAkihito Kawazoe, Kohei Shitara, Shota Fukuoka, et al.
BMC Cancer|April 18, 2015
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancerAkihito Kawazoe, Kohei Shitara, Shota Fukuoka, et al.
Pageof 10